Literature DB >> 27058934

First Approval of Regenerative Medical Products under the PMD Act in Japan.

Akihide Konishi1, Ken Sakushima2, Soichiro Isobe1, Daisaku Sato3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27058934     DOI： 10.1016/j.stem.2016.03.011

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  8 in total

Review 1.  Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.

Authors:  Brittany C Parker Kerrigan; Yuzaburo Shimizu; Michael Andreeff; Frederick F Lang
Journal:  Cytotherapy       Date:  2017-02-21       Impact factor: 5.414

2.  Trends in clinical trials for articular cartilage repair by cell therapy.

Authors:  Takaharu Negoro; Yuri Takagaki; Hanayuki Okura; Akifumi Matsuyama
Journal:  NPJ Regen Med       Date:  2018-10-11

3.  Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approval.

Authors:  Yoji Jokura; Kazuo Yano; Natsumi Watanabe; Masayuki Yamato
Journal:  Regen Ther       Date:  2016-10-10       Impact factor: 3.419

Review 4.  Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan.

Authors:  Teng-Huang Tsai; Thai-Yen Ling; Chung-Hsi Lee
Journal:  Clin Transl Sci       Date:  2020-06-07       Impact factor: 4.689

Review 5.  Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy.

Authors:  Yan Wu; Chunlei Zhang; Ran Guo; Dan Wu; Jiayi Shi; Luxin Li; Yanhui Chu; Xiaohuan Yuan; Jie Gao
Journal:  Stem Cells Int       Date:  2021-03-16       Impact factor: 5.443

Review 6.  Mesenchymal stem cell-based therapy for radiation-induced lung injury.

Authors:  Tiankai Xu; Yuyu Zhang; Pengyu Chang; Shouliang Gong; Lihong Shao; Lihua Dong
Journal:  Stem Cell Res Ther       Date:  2018-01-31       Impact factor: 6.832

Review 7.  Off-the-shelf mesenchymal stem cells from human umbilical cord tissue can significantly improve symptoms in COVID-19 patients: An analysis of evidential relations.

Authors:  Phuc Van Pham; Ngoc Bich Vu
Journal:  World J Stem Cells       Date:  2020-08-26       Impact factor: 5.326

8.  Recent Least Burdensome Approach for the Approval of Innovative Medical Devices in Japan -Regulatory Approval Review of an Everolimus-eluting Bioresorbable Scaffold.

Authors:  Akihide Konishi; Mami Ho; Yoshiaki Mitsutake; Takashi Ouchi; Masato Nakamura; Haruki Shirato
Journal:  Intern Med       Date:  2020-03-19       Impact factor: 1.271
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.